These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
545 related items for PubMed ID: 9802881
1. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. Patel V, Senderowicz AM, Pinto D, Igishi T, Raffeld M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS. J Clin Invest; 1998 Nov 01; 102(9):1674-81. PubMed ID: 9802881 [Abstract] [Full Text] [Related]
2. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1). Patel V, Lahusen T, Leethanakul C, Igishi T, Kremer M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS, Senderowicz AM. Clin Cancer Res; 2002 Nov 01; 8(11):3549-60. PubMed ID: 12429646 [Abstract] [Full Text] [Related]
9. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG, Bhalla K. Cancer Res; 2003 Jan 01; 63(1):93-9. PubMed ID: 12517783 [Abstract] [Full Text] [Related]
10. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases. Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, Mason KA, Milas L. Radiother Oncol; 2006 Aug 01; 80(2):185-91. PubMed ID: 16905211 [Abstract] [Full Text] [Related]
11. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma]. Song Y, Shen K, Tang PP. Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 01; 42(11):761-4. PubMed ID: 18307904 [Abstract] [Full Text] [Related]
20. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 01; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related] Page: [Next] [New Search]